MBRX - Moleculin Biotech stock slides on pricing $4.5 million securities offering
2023-12-21 01:31:33 ET
More on Moleculin Biotech
- Moleculin Biotech gains after early data for lead cancer therapy
- Seeking Alpha’s Quant Rating on Moleculin Biotech
- Historical earnings data for Moleculin Biotech
- Financial information for Moleculin Biotech
For further details see:
Moleculin Biotech stock slides on pricing $4.5 million securities offering